title: Switching antiretroviral therapy from an enzyme-inducing drug.
authors.affiliation: Department of Infectious Diseases, Karolinska Institute, Huddinge University Hospital, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Gyllensten
authors.forename: A
authors.initials: A
authors.lastname: Sönnerborg
authors.forename: L
authors.initials: L
authors.lastname: Ståhle
mesh_terms: D000328:Adult; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D019888:Nelfinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019438:Ritonavir / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D019888:Nelfinavir; D019438:Ritonavir